SCHEMBL3947415

SCHEMBL3947415

CC(Oc1ccc(C=O)cc1C#N)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
TSHR P16473 1/20 0.41
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39
S1PR5 Q9H228 1/20 0.39
SLC6A9 P48067 2/20 0.39
XDH P47989 3/20 0.38
RORC P51449 1/20 0.38
FDPS P14324 1/20 0.37
AOX1 Q06278 1/20 0.36
ESRRA P11474 1/20 0.35
KCNH2 Q12809 1/20 0.35
ALDH1A3 P47895 1/20 0.35
TTR P02766 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10088908 1.00 ALDH1A1 (0.41) ALDH1A1TSHRS1PR1S1PR3S1PR5
SCHEMBL2567289 0.86 ALDH1A1 (0.40) ALDH1A1TSHRS1PR1S1PR3S1PR5
SCHEMBL10088423 0.84 XDH (0.51) ALDH1A1TSHRXDHFDPSALDH1A3
SCHEMBL402072 0.79 XDH (0.46) ALDH1A1TSHRS1PR1S1PR3S1PR5
SCHEMBL399131 0.79 XDH (0.46) ALDH1A1TSHRS1PR1S1PR3S1PR5
SCHEMBL13678362 0.78 S1PR1 (0.39) ALDH1A1S1PR1S1PR3S1PR5SLC6A9
SCHEMBL1797074 0.78 AAK1 (0.45) ALDH1A1S1PR1S1PR3S1PR5SLC6A9
SCHEMBL13678296 0.78 S1PR1 (0.39) ALDH1A1S1PR1S1PR3S1PR5SLC6A9
SCHEMBL7136688 0.78 ALDH1A1 (0.43) ALDH1A1TSHRS1PR1FDPSAOX1
SCHEMBL1794470 0.77 ALDH1A1 (0.52) ALDH1A1S1PR1S1PR3S1PR5SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605171-B2 (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists MERCK & CO., INC. (US) 2009-10-20 US disclosed
EP-1697333-A4 (3,4-DISUBSTITUTED)PROPANOIC CARBOXYLATES AS S1P (EDG) RECEPTOR AGONISTS MERCK & CO INC (US) 2009-07-08 EP disclosed
US-20080249093-A1 (3,4-Disubstituted)Propanoic Carboxylates as Sip (Edg) Receptor Agonists MERCK & CO., INC. (US) 2008-10-09 US disclosed
CN-1894225-A (3, 4-disubstituted) propanoates as sphingosine 1-phosphate (endothelial differentiation gene) receptor agonists MERCK & CO INC (US) 2007-01-10 CN disclosed
EP-1697333-A1 (3,4-DISUBSTITUTED)PROPANOIC CARBOXYLATES AS S1P (EDG) RECEPTOR AGONISTS Merck & Co., Inc. (US) 2006-09-06 EP disclosed
WO-2005058848-A1 (3,4-DISUBSTITUTED)PROPANOIC CARBOXYLATES AS S1P (EDG) RECEPTOR AGONISTS MERCK & CO., INC. (US) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249093-A1 (3,4-Disubstituted)Propanoic Carboxylates as Sip (Edg) Receptor Agonists S1PR1, S1PR3, S1PR5 ALDH1A1 740/4885TSHR 1092/4885S1PR1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.